サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1671071

髄膜炎診断・治療市場、規模、シェア、動向、産業分析レポート：タイプ別、治療・診断別、エンドユーザー別、地域別 - 2025～2034年市場予測

Meningitis Diagnosis and Treatment Market Size, Share, Trends, Industry Analysis Report: By Type, Treatment & Diagnosis, End User, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 119 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
髄膜炎診断・治療市場、規模、シェア、動向、産業分析レポート：タイプ別、治療・診断別、エンドユーザー別、地域別 - 2025～2034年市場予測
出版日: 2025年02月01日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、髄膜炎診断・治療市場規模は2034年までに1億7,901万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

髄膜炎診断・治療市場は、髄膜炎、特に細菌性の髄膜炎の有病率の上昇と、迅速で正確な診断ソリューションに対する需要の高まりによって牽引されています。分子診断学の進歩と診断プロセスにおけるAIの統合は、効果的な治療に不可欠な病原体同定の速度と精度を高めています。特に新興の髄膜炎株に対するワクチン開発に重点が置かれつつあることは、市場開拓の大きな機会となっています。

さらに、十分なサービスを受けていない地域でのワクチン接種プログラムの拡大や、髄膜炎予防に関する一般市民の意識の高まりは、市場拡大のさらなる原動力となっています。市場は、標的療法の開発、診断技術の向上、世界のヘルスケア格差への取り組みの進行といった動向を目の当たりにしています。技術革新と治療への幅広いアクセスを継続的に推進することで、市場は今後数年間で安定した成長を遂げるものと思われます。

髄膜炎診断・治療市場レポート・ハイライト

細菌性髄膜炎分野は、疾患の重症度とタイムリーな治療の必要性から市場を独占していますが、認知度の向上と診断の改善によりウイルス性髄膜炎が最も急成長している分野です。

治療分野は抗生物質とワクチンの高い需要に牽引されて最大のシェアを占めていますが、診断分野は分子診断とAI技術の進歩により最も高い成長を遂げています。

病院・診療所は髄膜炎診断・治療の主要な場として市場をリードしていますが、診断ラボや外来診療を含むその他のセグメントが最も高い成長を示しています。この背景には、新興市場におけるヘルスケアアクセスの拡大があります。

北米は先進的なヘルスケア・インフラとワクチン接種プログラムにより髄膜炎診断・治療市場で最大のシェアを占めていますが、アジア太平洋地域は新興国での罹患率の上昇とヘルスケア拡大により最も高い成長を示しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の髄膜炎診断・治療市場の洞察

  • 市場スナップショット
  • 髄膜炎診断・治療市場力学
    • 促進要因と機会
      • AIと機械学習の統合
      • ハイスループット実験への移行
    • 抑制要因と課題
      • データ量の不足
  • PESTEL分析
  • 髄膜炎診断・治療市場のアプリケーション動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の髄膜炎診断・治療市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • ウイルス性髄膜炎
  • 細菌性髄膜炎
  • その他

第6章 世界の髄膜炎診断・治療市場：治療・診断別

  • 主な調査結果
  • イントロダクション
  • 治療
  • 診断

第7章 世界の髄膜炎診断・治療市場：エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院・クリニック
  • その他

第8章 世界の髄膜炎診断・治療市場：地域

  • 主な調査結果
  • イントロダクション
    • 髄膜炎診断・治療市場の評価：地域、2020～2034年
  • 北米
    • 北米：タイプ別、2020～2034年
    • 北米：治療・診断別、2020年～2034年
    • 北米：エンドユーザー別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：タイプ別、2020～2034年
    • 欧州：治療・診断別、2020～2034年
    • 欧州：エンドユーザー別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域：タイプ別、2020～2034年
    • アジア太平洋地域：治療・診断別、2020年～2034年
    • アジア太平洋地域：エンドユーザー別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別、2020～2034年
    • 中東・アフリカ：治療・診断別、2020～2034年
    • 中東・アフリカ：エンドユーザー別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別、2020～2034年
    • ラテンアメリカ：治療・診断別、2020～2034年
    • ラテンアメリカ：エンドユーザー別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Pfizer Inc.
  • Merck & Co., Inc.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Novartis AG
  • Johnson & Johnson
  • Roche Holding AG
  • Abbott Laboratories
  • Siemens Healthineers
  • bioMerieux S.A.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Mylan N.V.（now part of Viatris Inc.）
  • Hologic, Inc.
  • Cepheid, Inc.
図表

List of Tables:

  • Table 1 Global Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 2 Global Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 3 Global Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 4 North America: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 5 North America: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 6 North America: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 7 U.S.: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 8 U.S.: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 9 U.S.: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 10 Canada: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 11 Canada: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 12 Canada: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 13 Europe: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 14 Europe: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 15 Europe: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 16 UK: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 17 UK: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 18 UK: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 19 France: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 20 France: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 21 France: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 22 Germany: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 23 Germany: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 24 Germany: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 25 Italy: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 26 Italy: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 27 Italy: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 28 Spain: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 29 Spain: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 30 Spain: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 31 Netherlands: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 33 Netherlands: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 34 Russia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 35 Russia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 36 Russia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 43 China: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 44 China: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 45 China: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 46 India: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 47 India: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 48 India: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 49 Malaysia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 51 Malaysia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 52 Japan: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 53 Japan: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 54 Japan: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 55 Indonesia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 57 Indonesia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 58 South Korea: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 60 South Korea: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 61 Australia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 62 Australia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 63 Australia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 73 UAE: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 74 UAE: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 75 UAE: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 76 Israel: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 77 Israel: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 78 Israel: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 79 South Africa: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 81 South Africa: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 85 Latin America: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 87 Latin America: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 88 Mexico: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 90 Mexico: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 91 Brazil: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 93 Brazil: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 94 Argentina: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 96 Argentina: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Meningitis Diagnosis and Treatment Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Meningitis Diagnosis and Treatment Market, by Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Treatment & Diagnosis
  • Figure 9. Global Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2024 & 2034 (USD Million)
  • Figure 10. Market by End-User
  • Figure 11. Global Meningitis Diagnosis and Treatment Market, by End-User, 2024 & 2034 (USD Million)
目次
Product Code: PM1593

The meningitis diagnosis and treatment market size is expected to reach USD 179.01 million by 2034, according to a new study by Polaris Market Research. The report "Meningitis Diagnosis and Treatment Market Size, Share, Trends, Industry Analysis Report: By Type (Viral Meningitis, Bacterial Meningitis, and Others), Treatment & Diagnosis, End User (Hospitals & Clinics and Others), and Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The meningitis diagnosis and treatment market is driven by the rising prevalence of meningitis, particularly bacterial forms, and the increasing demand for rapid, accurate diagnostic solutions. Advancements in molecular diagnostics and the integration of AI in diagnostic processes are enhancing the speed and precision of pathogen identification, which is crucial for effective treatment. The growing focus on vaccine development, particularly for emerging strains of meningitis, presents significant opportunities for market growth.

Additionally, expanding vaccination programs in underserved regions and increasing public awareness about meningitis prevention further fuel market expansion. The market is witnessing trends such as the development of targeted therapies, improved diagnostic technologies, and the ongoing efforts to address global healthcare disparities. With a continuous push toward innovation and broader access to treatments, the market is poised for steady growth in the coming years.

Meningitis Diagnosis and Treatment Market Report Highlights

The bacterial meningitis segment dominates the market due to the severity of the disease and the critical need for timely treatments, although viral meningitis is the fastest-growing segment with increasing awareness and diagnostic improvements.

The treatment segment holds the largest share, driven by the high demand for antibiotics and vaccines, while the diagnosis segment is experiencing the highest growth due to advancements in molecular diagnostics and AI technologies.

Hospitals & clinics lead the market as the primary setting for meningitis diagnosis and treatment, while the others segment, including diagnostic labs and outpatient care, is witnessing the highest growth. This is driven by expanding healthcare access in emerging markets.

North America holds the largest meningitis diagnosis and treatment market share due to advanced healthcare infrastructure and vaccination programs, while Asia Pacific is the highest-growing, fueled by rising incidence and healthcare expansion in developing countries.

Polaris Market Research has segmented the meningitis diagnosis and treatment market report based on type, treatment & diagnosis, end user, and region:

By Type Outlook (Revenue-USD Million, 2020 - 2034)

  • Viral Meningitis
  • Bacterial Meningitis
  • Others

By Treatment & Diagnosis Outlook (Revenue-USD Million, 2020 - 2034)

  • Treatment
  • Diagnosis

By End-User Outlook (Revenue-USD Million, 2020 - 2034)

  • Hospitals & Clinics
  • Others

By Regional Outlook (Revenue-USD Million, 2020 - 2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Meningitis Diagnosis and Treatment Market Insights

  • 4.1. Meningitis Diagnosis and Treatment Market - Market Snapshot
  • 4.2. Meningitis Diagnosis and Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Integration of AI and Machine Learning
      • 4.2.1.2. Shift Toward High-Throughput Experimentation
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Insufficient data volume
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Meningitis Diagnosis and Treatment Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Meningitis Diagnosis and Treatment Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
  • 5.3. Viral Meningitis
    • 5.3.1. Global Meningitis Diagnosis and Treatment Market, by Viral Meningitis, by Region, 2020-2034 (USD Million)
  • 5.4. Bacterial Meningitis
    • 5.4.1. Global Meningitis Diagnosis and Treatment Market, by Bacterial Meningitis, by Region, 2020-2034 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Meningitis Diagnosis and Treatment Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
  • 6.3. Treatment
    • 6.3.1. Global Meningitis Diagnosis and Treatment Market, by Treatment, by Region, 2020-2034 (USD Million)
  • 6.4. Diagnosis
    • 6.4.1. Global Meningitis Diagnosis and Treatment Market, by Diagnosis, by Region, 2020-2034 (USD Million)

7. Global Meningitis Diagnosis and Treatment Market, by End-User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Global Meningitis Diagnosis and Treatment Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
  • 7.4. Others
    • 7.4.1. Global Meningitis Diagnosis and Treatment Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Meningitis Diagnosis and Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Meningitis Diagnosis and Treatment Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Meningitis Diagnosis and Treatment Market - North America
    • 8.3.1. North America: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
    • 8.3.3. North America: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.3.4. Meningitis Diagnosis and Treatment Market - U.S.
      • 8.3.4.1. U.S.: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.3.5. Meningitis Diagnosis and Treatment Market - Canada
      • 8.3.5.1. Canada: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • 8.4. Meningitis Diagnosis and Treatment Market - Europe
    • 8.4.1. Europe: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
    • 8.4.3. Europe: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.4.4. Meningitis Diagnosis and Treatment Market - UK
      • 8.4.4.1. UK: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.4.5. Meningitis Diagnosis and Treatment Market - France
      • 8.4.5.1. France: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.4.5.3. France: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.4.6. Meningitis Diagnosis and Treatment Market - Germany
      • 8.4.6.1. Germany: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.4.7. Meningitis Diagnosis and Treatment Market - Italy
      • 8.4.7.1. Italy: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.4.8. Meningitis Diagnosis and Treatment Market - Spain
      • 8.4.8.1. Spain: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.4.9. Meningitis Diagnosis and Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.4.10. Meningitis Diagnosis and Treatment Market - Russia
      • 8.4.10.1. Russia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.4.11. Meningitis Diagnosis and Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • 8.5. Meningitis Diagnosis and Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.5.4. Meningitis Diagnosis and Treatment Market - China
      • 8.5.4.1. China: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.5.4.3. China: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.5.5. Meningitis Diagnosis and Treatment Market - India
      • 8.5.5.1. India: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.5.5.3. India: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.5.6. Meningitis Diagnosis and Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.5.7. Meningitis Diagnosis and Treatment Market - Japan
      • 8.5.7.1. Japan: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.5.8. Meningitis Diagnosis and Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.5.9. Meningitis Diagnosis and Treatment Market - South Korea
      • 8.5.9.1. South Korea: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.5.10. Meningitis Diagnosis and Treatment Market - Australia
      • 8.5.10.1. Australia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.5.11. Meningitis Diagnosis and Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • 8.6. Meningitis Diagnosis and Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.6.4. Meningitis Diagnosis and Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.6.5. Meningitis Diagnosis and Treatment Market - UAE
      • 8.6.5.1. UAE: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.6.6. Meningitis Diagnosis and Treatment Market - Israel
      • 8.6.6.1. Israel: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.6.7. Meningitis Diagnosis and Treatment Market - South Africa
      • 8.6.7.1. South Africa: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.6.8. Meningitis Diagnosis and Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
  • 8.7. Meningitis Diagnosis and Treatment Market - Latin America
    • 8.7.1. Latin America: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.7.4. Meningitis Diagnosis and Treatment Market - Mexico
      • 8.7.4.1. Mexico: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.7.5. Meningitis Diagnosis and Treatment Market - Brazil
      • 8.7.5.1. Brazil: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.7.6. Meningitis Diagnosis and Treatment Market - Argentina
      • 8.7.6.1. Argentina: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
    • 8.7.7. Meningitis Diagnosis and Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Pfizer Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Merck & Co., Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Sanofi S.A.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. GlaxoSmithKline plc
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Novartis AG
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Johnson & Johnson
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Roche Holding AG
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Abbott Laboratories
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Siemens Healthineers
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. bioMerieux S.A.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Becton, Dickinson and Company
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Thermo Fisher Scientific Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Mylan N.V. (now part of Viatris Inc.)
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Hologic, Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Cepheid, Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development